Abstract | BACKGROUND: MATERIALS AND METHODS: The VEGF secretion model of acute retinal pigment epithelial-19 (ARPE-19) cells under chemical hypoxia was established by the exposure of cells to 150 μM CoCl2 and then cells were treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1, a potent HIF-1α inhibitor, 1.0 μg/mL) or different concentrations of FMN (0.2 μg/mL, 1.0 μg/mL, and 5.0 μg/mL). The supernatants of cells were collected 48 hours later to measure the VEGF concentrations, following the manufacturer's instruction. The mRNA expressions of VEGF, HIF-1α, PHD-2, and β-actin were analyzed by quantitative reverse transcription polymerase chain reaction, and the protein expressions of HIF-1α and PHD-2 were determined by Western blot analysis. Furthermore, the rats with retinopathy were treated by intraperitoneal administration of conbercept injection (1.0 mg/kg) or FMN (5.0 mg/kg and 10.0 mg/kg) in an 80% oxygen atmosphere. The retinal avascular areas were assessed through visualization of the retinal vasculature by adenosine diphosphatase staining and hematoxylin and eosin staining. RESULTS:
FMN can indeed inhibit the VEGF secretion of ARPE-19 cells under hypoxia, downregulate the mRNA expression of VEGFA and PHD-2, and decrease the protein expression of VEGF, HIF-1α, and PHD-2 in vitro. Furthermore, FMN can prevent hypoxia-induced retinal NV in vivo. CONCLUSION:
|
Authors | Jianming Wu, Xiao Ke, Na Ma, Wei Wang, Wei Fu, Hongcheng Zhang, Manxi Zhao, Xiaoping Gao, Xiaofeng Hao, Zhirong Zhang |
Journal | Drug design, development and therapy
(Drug Des Devel Ther)
Vol. 10
Pg. 3071-3081
( 2016)
ISSN: 1177-8881 [Electronic] New Zealand |
PMID | 27729769
(Publication Type: Journal Article)
|
Chemical References |
- HIF1A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Isoflavones
- Vascular Endothelial Growth Factors
- formononetin
|
Topics |
- Animals
- Astragalus propinquus
(chemistry)
- Cell Hypoxia
(drug effects)
- Cells, Cultured
- Dose-Response Relationship, Drug
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(biosynthesis, metabolism)
- Isoflavones
(administration & dosage, pharmacology)
- Molecular Structure
- Rats
- Rats, Sprague-Dawley
- Retinal Neovascularization
(drug therapy, metabolism)
- Signal Transduction
(drug effects)
- Structure-Activity Relationship
- Vascular Endothelial Growth Factors
(biosynthesis, metabolism)
|